Epizyme, Inc. Uncategorized Contracts & Agreements
28 Contracts & Agreements
- Form of Contingent Value Rights Agreement (Filed With SEC on June 27, 2022)
- Form of Support Agreement (Filed With SEC on June 27, 2022)
- Second Amendment to the Companion Diagnostics Agreement dated November 16, 2015 between the Registrant and Eisai Co. Ltd. on the one side and Roche Molecular Systems, Inc. on the... (Filed With SEC on March 1, 2022)
- First Amendment to the Companion Diagnostics Agreement dated October 23, 2013 between the Registrant and Eisai Co. Ltd. on the one side and Roche Molecular Systems, Inc. on the... (Filed With SEC on March 1, 2022)
- Companion Diagnostics Agreement dated as of December 18, 2012 between the Registrant and Eisai Co., Ltd. on the one side and Roche Molecular Systems, Inc. on the other side (Filed With SEC on March 1, 2022)
- Description of Securities of the Registrant (Filed With SEC on February 27, 2020)
- - 2 - (Filed With SEC on May 6, 2016)
- Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions. (Filed With SEC on March 9, 2016)
- Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions. (Filed With SEC on August 6, 2015)
- Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions. (Filed With SEC on March 12, 2015)
- EPIZYME, INC. RESTRICTED STOCKUNIT AGREEMENT (Filed With SEC on March 12, 2015)
- - 2 - (Filed With SEC on February 3, 2015)
- - 2 - (Filed With SEC on November 6, 2014)
- Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions. (Filed With SEC on April 22, 2014)
- Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions. (Filed With SEC on April 22, 2014)
- Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions. (Filed With SEC on January 27, 2014)
- Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions. (Filed With SEC on May 13, 2013)
- Confidential Materials omitted and filed separately with the Securities andExchange Commission. Double asterisks denote omissions. (Filed With SEC on May 13, 2013)
- Confidential Materials omitted and filed separately with the Securities andExchange Commission. Double asterisks denote omissions. (Filed With SEC on May 13, 2013)
- Confidential Materials omitted and filed separately with the Securities andExchange Commission. Double asterisks denote omissions. (Filed With SEC on May 13, 2013)
- [Company Letterhead] (Filed With SEC on April 26, 2013)
- [Company Letterhead] (Filed With SEC on April 26, 2013)
- [Company Letterhead] (Filed With SEC on April 26, 2013)
- [Company Letterhead] (Filed With SEC on April 26, 2013)
- Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions. (Filed With SEC on April 18, 2013)
- Confidential Materials omitted and filed separately with the Securities andExchange Commission. Double asterisks denote omissions. (Filed With SEC on April 18, 2013)
- Confidential Materials omitted and filed separately with the Securities andExchange Commission. Double asterisks denote omissions. (Filed With SEC on April 18, 2013)
- Confidential Materials omitted and filed separately with the Securities andExchange Commission. Double asterisks denote omissions. (Filed With SEC on April 18, 2013)
